Places available


Deadline for application



 What we need

- Graduated as a Lab Technician in Clinical and Biomedical Analysis.
- Experience in lab managing, provisioning and purchasing.
- Previous experience as a lab technician and specifically working with patient samples is required.
- Valid certification for animal experimentation.
- Experience in molecular biology and biochemistry techniques will be positively considered.
- Intermediate level of English (it will be evaluated during the interview).


Main responsibilities

- Managing and provisioning of the laboratory.
- Reception of samples and reagents.
- Mouse colony managing.
- Patient sample processing.
- Experimental technical support.


What we offer

- Full time job.
- Temporary position.
- An exciting and innovative research project.
- Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
- The stimulating environment of the Barcelona metropolitan area.

Additional Information

The Josep Carreras Leukaemia Research Institute (IJC) is a nonprofit research institute based in Barcelona and dedicated to advancing our understanding about leukaemia and related disorders, in partnership with the University of Barcelona and University Autònoma of Barcelona. The IJC has laboratories in three clinical campuses: i) Clinic Hospital, ii) Sant Pau Hospital and iii) Germans Trias i Pujol Hospital. IJC serves as a collaborative hub for basic investigators and physicians to work together on fundamental biological and clinical aspects of leukaemia. The IJC offers an excellent work environment built around a multi-disciplinary fusion of ideas and state-of-the-art facilities


Research Description

IJC Campus ICO-GTIP (Badalona) is looking for a Laboratory Technician to join the Leukemia and Immuno-Oncology group, led by Dr. Laura Belver. Our research is focused on the study of the molecular mechanisms driving leukemogenesis and on the identification of new therapeutic targets that can potentially translate into novel strategies for the treatment of leukemia patients. More specifically, one of our main interests is to identify and characterize non-coding genetic alterations that can induce aberrant enhancer activity, and function as drivers of leukemia transformation or contribute to leukemia progression through other means.

In addition, we are interested in the specific role of the immune system in developing antitumor responses. In particular, we will focus on the molecular characterization of the beneficial and deleterious responses induced by the use of immune-checkpoint inhibitors for the treatment of different tumor types.

This contract will be funded by the Ministry of Science and Innovation (AEI), under the call for R&D&I 2020 projects, file number PID2020-117645RB-I00.

Please also visit our group webpage:


Who we are?

Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukaemia and other hematologic malignancies.

The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments.  We aspire to understand the origin and development of leukaemia and other malignant haematological pathologies in order to be able to prevent them.  We will work for a future in which all leukaemia will be curable.

For further information, please, visit our webpage: and the Josep Carreras non-profit organization:

The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.

The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.

This EC initiative aims to promote training, professional development, and mobility for all European scientists.  The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favours the development of its scientists.

IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, colour, religion, sex, national origin, disability, and other legally protected characteristics.

Place of presentation of the candidacies

How to apply

To apply for this opportunity, please send your resume and a cover letter and (incl. the contact details of two referees) to including the reference LABT_LB_77


Deadline for Applications:

Please submit your application by September 22th, 2021.  

Enlaces relacionados